Treat it right with Grand-Pa

*We do not supply our products directly to consumers. By selecting the Buy Now button on this page, you will be re-directed to a list of retailers’ websites for purchase. Kindly note that purchase will be subject to stock availability

Promotion of Access to Information Act (PAIA)

The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.

Please see the PAIA manual.

*Ready to work in 10 seconds refers to Grand-Pa powders, based on dissolution data mimicking the gastric environment and not on illustrative clinical effect.
Reference: GSK Data on file, 2015.

S0 GRAND-PA Headache Powders. Each powder contains: Aspirin 453,6 mg; Paracetamol 324,0 mg; Caffeine 64,8 mg. Reg. No.: B/2.9/1113.

S0 GRAND-PA Headache Tablets. Each tablet contains: Aspirin 226,8 mg; Paracetamol 162,0 mg; Caffeine 32,4 mg. Reg. No.: P/2.9/22.

Haleon South Africa (Pty) Ltd. 11 Hawkins Avenue, Epping Industria 1, Cape Town, 7460. Reg. No: 2014/173930/07. For full prescribing information refer to the professional information approved by the medicines regulatory authority. For any further information, including safety, adverse reactions, please contact the Haleon Hotline on 0800 007 018, mystory.za@haleon.com.
Always read the label before/prior use
Trademarks are owned by or licensed to Haleon group of companies.

Members of: Marketing Code Authority: info@marketingcode.co.za, Tel. No. +27 63 044 5200.